Ligand · LKG
LKG · 4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol
LKG, 4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol (C18 H14 N4 O, 302.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it…
- Component
- LKG
- Formula
- C18 H14 N4 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LKG in 2 structures; the first of them:
- 3CCN · X-ray structure of c-Met with triazolopyridazine inhibitor. · LKG A1 · binds ILE1084, GLY1085, VAL1092, ALA1108, LEU1140, LEU1157, PRO1158, TYR1159 and 10 more
- 3CCN · X-ray structure of C-met with triazolopyridazine inhibitor. · LKG A1 · binds ILE1084, GLY1085, VAL1092, ALA1108, LEU1140, LEU1157, PRO1158, TYR1159 and 10 more
Residues it binds most
ALA 2, ASN 2, ASP 2, LEU 2, MET 2, TYR 2, ARG 2, GLY 2, ILE 2, PRO 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.